about
Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palateThe differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.Birth defects data from population-based birth defects surveillance programs in the United States, 2007 to 2011: highlighting orofacial clefts.Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient miceEndogenous osteopontin promotes ozone-induced neutrophil recruitment to the lungs and airway hyperresponsiveness to methacholineFirst-trimester screening and its impact on uptake of diagnostic testing.Studying the effects of maternal febrile exposures on neurological outcomes in offspring: conceptual and methodological issues.Decreased exhaled nitric oxide levels in patients with mitochondrial disordersLoss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.Self-reported reproductive health in women with tuberous sclerosis complex.The association between neonatal thyroxine and craniosynostosis, Texas, 2004-2007.Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.Multicenter study of mortality in achondroplasiaAssociation between thyroxine levels at birth and choanal atresia or stenosis among infants in Texas, 2004-2007Maternal use of hot tub and major structural birth defectsSurvival of Texas infants born with trisomies 21, 18, and 13Idiopathic talipes equinovarus (ITEV) (clubfeet) in TexasPrevalence of nonsyndromic oral clefts in Texas: 1995-1999Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliteransMortality in babies with achondroplasia: RevisitedImpaired Gastric Emptying and Small Bowel Transit in Children With Mitochondrial Disorders
P50
Q24607738-5EB8127B-69FC-4AD7-92AA-2373CBFBCE3EQ30518266-2F955112-47B4-4C51-8B59-67F8E6E81682Q30870008-3D084520-ED6A-47CD-887D-127735DAD4C7Q34201199-7D023529-28A5-4969-915D-DB5C1A844FB6Q37054496-63B04C27-CF08-4F6E-8000-87EBA1649494Q37892477-7B3290B5-8803-40F7-B490-03DBD42C006BQ40160383-64A203A9-BBA1-4481-BDB7-434AB49832F8Q41811395-909D6DB3-98FD-452A-B065-29B597FA9272Q45339901-95C6A6E5-FBFF-40E2-8B88-3586846FD2DFQ45962222-E82B881B-12FF-450A-A8BE-83A1BE922978Q45994234-AF08D182-6AC5-47A0-8610-B09E73AFBB4BQ54321406-013F862D-3F2C-4E73-9D18-FB47FE7888EAQ57051449-E3135CCC-0DA3-4974-BAF2-B9DB65B227B7Q57269527-0AAD5CD6-C7F3-4D7E-A694-15F72E24AAADQ60213651-A490D60F-4022-4E5A-A492-271690690BCAQ60213660-6191F4BB-68BF-4E99-B81E-1F7B4001A72FQ60213703-B5CD4F23-ADE2-4C84-A119-6E4E23CD2491Q60213709-29A9FFEF-EE1C-4C13-8B6D-2ECA25DBBA05Q63560648-8B1D6718-CBE2-474B-8272-6268329F48FEQ63560651-4C105B74-0288-4E33-B8F5-19A711C0BFDDQ63560655-911CA619-5F45-471D-9169-FF97D4491267
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Syed Shahrukh Hashmi
@ast
Syed Shahrukh Hashmi
@en
Syed Shahrukh Hashmi
@es
Syed Shahrukh Hashmi
@nl
Syed Shahrukh Hashmi
@sl
type
label
Syed Shahrukh Hashmi
@ast
Syed Shahrukh Hashmi
@en
Syed Shahrukh Hashmi
@es
Syed Shahrukh Hashmi
@nl
Syed Shahrukh Hashmi
@sl
prefLabel
Syed Shahrukh Hashmi
@ast
Syed Shahrukh Hashmi
@en
Syed Shahrukh Hashmi
@es
Syed Shahrukh Hashmi
@nl
Syed Shahrukh Hashmi
@sl
P106
P1153
8566710300
P21
P31
P496
0000-0001-8758-8254